对于快速进展的儿童近视症 (ARM研究) 的阿特罗平 (0.05%)
Rohit Saxena1, Vinay Gupta, Himani Thakur
1Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian journal of ophthalmology
|December 27, 2024
概括
低剂量阿特罗平眼滴有效地减少了近视的进展,在儿童的视力迅速恶化. 这种近视控制治疗显示,近视的进展减少了62%,并且在一年内没有副作用.
科学领域:
- 眼科医生 眼科 眼科
- 儿科眼科医生 儿科眼科医生
- 临床研究 临床研究
背景情况:
- 近视,或近视,是一个日益增长的全球健康问题,特别是在儿童中.
- 儿童时期近视的快速进展可能会增加晚年出现严重眼睛疾病的风险.
- 有效的近视控制策略对于保持长期视力健康至关重要.
研究的目的:
- 评估低剂量0.05%的阿特罗宾在控制儿童近视的快速进展方面的疗效.
- 为了评估一年治疗期间的折射误差和轴长度的变化.
- 为了记录与阿特罗宾0.05%使用相关的任何不良反应.
主要方法:
- 进行了一项前性单臂临床试验,涉及6至12岁的儿童,近视的进展超过每年0.75D.
- 参与者每天晚上接受0.05%的氨酸眼滴,持续一年.
- 主要结局包括近视进展率的变化 (二眼/年),球体等效折射误差 (SER) 和轴长 (AL).
主要成果:
- 用0.05%的氨酸治疗导致近视进展率显著减少62%, (P<0.001).
- 平均进展率从基线时的-1.05 D/年下降到一年后的-0.4 D/年.
- 没有报告任何显著的不良影响,治疗反应与基线特征独立.
结论:
- 氨酸0.05%是一种安全有效的治疗方法,用于治疗儿童快速进展的近视.
- 这种低剂量氨酸治疗为近视控制提供了一个有前途的选择,具有有利的副作用概况.
- 进一步的研究可能会探索长期结果和最佳剂量策略.
相关概念视频
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
683
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
683
01:27Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
614
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
614
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
01:28Angle Closure Glaucoma: Treatment
435
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
435